Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna L Parks

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Hematology. American Society of Hematology. Education Program|December 7, 2024
Anticoagulation at the end of life: whether, when, and how to treatAnna L Parks
Journal of Hospital Medicine|November 8, 2024
A sobering reminder and call to action: Preventing inpatient deaths from pulmonary emboli with a wraparound strategyAnna L Parks
Journal of Hospital Medicine|October 2, 2025
Rethinking the threshold: Timing matters in red blood cell transfusions during hospitalizationAnna L Parks
JAMA Internal Medicine|February 17, 2025
Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance: A ReviewYuxin Liu, Anna L Parks
Seminars in Thrombosis and Hemostasis|March 31, 2017
Scoring Systems for Estimating the Risk of Anticoagulant-Associated BleedingAnna L Parks, Margaret C Fang
JAMA Internal Medicine|December 20, 2016
Women in Medicine and Patient Outcomes: Equal Rights for Better Work?Anna L Parks, Rita F Redberg
Annals of Internal Medicine|December 4, 2023
NSAIDs and hormonal contraceptives are linked to VTE in women with no previous thrombotic diseaseAnna L Parks, Scott M Stevens
JAMA Internal Medicine|May 2, 2017
Dabigatran Compared With Rivaroxaban vs Warfarin-ReplyAnna L Parks, Rita F Redberg
JAMA Internal Medicine|May 10, 2021
Anticoagulation at the End of Life: Time for a Rational FrameworkAnna L Parks, Kenneth E Covinsky
JAMA Internal Medicine|January 1, 2016
Teaching High-Value Care on Rounds: Modeling ModerationRachel J Stern, Anna L Parks
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Hematology. American Society of Hematology. Education Program|December 7, 2024
Anticoagulation at the end of life: whether, when, and how to treatAnna L Parks
Journal of Hospital Medicine|November 8, 2024
A sobering reminder and call to action: Preventing inpatient deaths from pulmonary emboli with a wraparound strategyAnna L Parks
Journal of Hospital Medicine|October 2, 2025
Rethinking the threshold: Timing matters in red blood cell transfusions during hospitalizationAnna L Parks
JAMA Internal Medicine|February 17, 2025
Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance: A ReviewYuxin Liu, Anna L Parks
Seminars in Thrombosis and Hemostasis|March 31, 2017
Scoring Systems for Estimating the Risk of Anticoagulant-Associated BleedingAnna L Parks, Margaret C Fang
JAMA Internal Medicine|December 20, 2016
Women in Medicine and Patient Outcomes: Equal Rights for Better Work?Anna L Parks, Rita F Redberg
Annals of Internal Medicine|December 4, 2023
NSAIDs and hormonal contraceptives are linked to VTE in women with no previous thrombotic diseaseAnna L Parks, Scott M Stevens
JAMA Internal Medicine|May 2, 2017
Dabigatran Compared With Rivaroxaban vs Warfarin-ReplyAnna L Parks, Rita F Redberg
JAMA Internal Medicine|May 10, 2021
Anticoagulation at the End of Life: Time for a Rational FrameworkAnna L Parks, Kenneth E Covinsky
JAMA Internal Medicine|January 1, 2016
Teaching High-Value Care on Rounds: Modeling ModerationRachel J Stern, Anna L Parks
Pageof 6